Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEP) EBT Margin (2025)

Historic EBT Margin for Coeptis Therapeutics Holdings (COEP) over the last 1 years, with Q3 2025 value amounting to 1220.84%.

  • Coeptis Therapeutics Holdings' EBT Margin changed N/A to 1220.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 2727.78%, marking a year-over-year change of. This contributed to the annual value of 17932.37% for FY2021, which is N/A changed from last year.
  • Latest data reveals that Coeptis Therapeutics Holdings reported EBT Margin of 1220.84% as of Q3 2025.
  • Coeptis Therapeutics Holdings' 5-year EBT Margin high stood at 1220.84% for Q3 2025, and its period low was 5440.95% during Q1 2025.